Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma

Genes Chromosomes and Cancer

Volumn 49, Issue 6, 2010, Pages 518-525

  Mejia Guerrero, Salvador ^a   Quejada, Michael ^a   Gokgoz, Nalan ^a   Gill, Mona ^a   Parkes, Robert K ^a   Wunder, Jay S ^a,b   Andrulis, Irene L ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2;

ADOLESCENT; ADULT; AGED; AMPLICON; ARTICLE; CELL CYCLE PROGRESSION; CHILD; CHROMOSOME 12Q; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENES, P53; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTATION; OSTEOSARCOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; YOUNG ADULT;

EID: 77952087785     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20761     Document Type: Article

References (44)

1. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA. 2003. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36:7-16. (Pubitemid 36077377)
2. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W. 2001. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20:1630-1639. (Pubitemid 32299400)
3. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O. 1996. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17:254-259. (Pubitemid 26424003)
4. Bovenkerk S, Lanciloti N, Chandar N. 2003. Induction of p53 expression and function by estrogen in osteoblasts. Calcif Tissue Int 73:274-280. (Pubitemid 37152889)
5. Burkhart DL, Sage J. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8:671-682.
6. Deb SP. 2003. Cell cycle regulatory functions of the human oncoprotein MDM2. Mol Cancer Res 1:1009-1016.
7. Elkahloun AG, Bittner M, Hoskins K, Gemmill R, Meltzer PS. 1996. Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers. Genes Chromosomes Cancer 17:205-214. (Pubitemid 26423998)
8. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, Geurts van Kessel A. 1995. Comparative genomic hybridization analysis of human sarcomas. II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 14:15-21.
9. Gamberi G, Ragazzini P, Benassi MS, Ferrari C, Sollazzo MR, Molendini L, Merli M, Magagnoli G, Ruggieri P, Balladelli A, Orlando C, Bacchini P, Pazzagli M, Picci P. 2000. Analysis of 12q13-15 genes in parosteal osteosarcoma. Clin Orthop Relat Res 377:195-204. (Pubitemid 30614885)
10. Gisselsson D, Palsson E, Hoglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl N. 2002. Differentially amplified chromosome 12 sequences in low- and highgrade osteosarcoma. Genes Chromosomes Cancer 33:133-140. (Pubitemid 34052494)
11. Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, Andrulis IL. 2001. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 92:2181-2189. (Pubitemid 32973330)
12. Gotoh N. 2008. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99:1319-1325. (Pubitemid 351761719)
13. Heidenblad M, Hallor KH, Staaf J, Jonsson G, Borg A, Hoglund M, Mertens F, Mandahl N. 2006. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene 25:7106-7116. (Pubitemid 44722078)
14. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC. 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551-3555. (Pubitemid 24299821)
15. Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pelissier S, Coindre JM. 2004. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: A potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 202:95-102. (Pubitemid 38072850)
16. Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P, Leroux A, Mainguene C, Peyrottes I, Ranchere-Vince D, Terrier P, Tran A, Gual P, Pedeutour F. 2008. HMGA2 is the partner of MDM2 in welldifferentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122:2233-2241. (Pubitemid 351542325)
17. Klein MJ, Siegal GP. 2006. Osteosarcoma: Anatomic and histologic variants. Am J Clin Pathol 125:555-581.
18. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. 1993. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18. (Pubitemid 23019370)
19. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH. 1995. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J Pathol 175:211-217.
20. Lee MH, Yang HY. 2003. Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev 22:435-449.
21. Llanos S, Efeyan A, Monsech J, Dominguez O, Serrano M. 2006. A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle 5:1880-1885. (Pubitemid 44435334)
22. Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. 1997. p53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate. Cancer 79:1541-1547. (Pubitemid 27154785)
23. Lopes MA, Nikitakis NG, Ord RA, Sauk J,Jr. 2001. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol 37:566-571.
24. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH. 2004. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4:45. (Pubitemid 40180241)
25. Martin DN, Mikhail IS, Landgren O. 2009. Autoimmunity and hematologic malignancies: Associations and mechanisms. Leuk Lymphoma 50:541-550.
26. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP. 1996. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 122:559-565. (Pubitemid 26284557)
27. Mitra RS, Zhang Z, Henson BS, Kurnit DM, Carey TE, D'silva NJ. 2003. Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: Nuclear translocation of GTP-bound active form. Oncogene 22:6243-6256.
28. Muthusamy V, Hobbs C, Nogueira C, Cordon-Cardo C, McKee PH, Chin L, Bosenberg MW. 2006. Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer 45:447-454.
29. Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS. 1995. MDM2 gene amplification in bone and softtissue tumors: Association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer 64:342-346.
30. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
31. Onel K, Cordon-Cardo C. 2004. MDM2 and prognosis. Mol Cancer Res 2:1-8.
32. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. 1999. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41. (Pubitemid 28544460)
33. Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F, Picci P, Benassi MS. 2004. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 19:401-411. (Pubitemid 38443902)
34. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. 1993. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739. (Pubitemid 23180507)
35. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. 1996. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 56:5141-5145. (Pubitemid 26383027)
36. Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G. 2002. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 21:2476-2483. (Pubitemid 34438100)
37. Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K. 2007. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 25:725-738. (Pubitemid 46341924)
38. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S. 1999. DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84:114-121. (Pubitemid 29133820)
39. Tsakiris I, Soos G, Nemes Z, Kiss SS, Andras C, Szanto J, Dezso B. 2008. The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: The coexistence predicts a poor prognosis regardless of EGFR levels. J Cancer Res Clin Oncol 134:439-451. (Pubitemid 351322380)
40. Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M. 1999. CDK4 gene amplification in osteosarcoma: Reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 80:199-204. (Pubitemid 29001722)
41. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner JM, Myklebost O, Knuutila S. 1997. Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis. Genes Chromosomes Cancer 18:66-70. (Pubitemid 27020258)
42. Wunder JS, Eppert K, Burrow SR, Gokgoz N, Bell RS, Andrulis IL. 1999. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 18:783-788. (Pubitemid 29080336)
43. Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL. 2005. TP53 mutations and outcome in osteosarcoma: A prospective, multicenter study. J Clin Oncol 23:1483-1490. (Pubitemid 46260036)
44. Yan T, Wunder JS, Gokgoz N, Gill M, Eskandarian S, Parkes RK, Bull SB, Bell RS, Andrulis IL. 2007. COPS3 amplification and clinical outcome in osteosarcoma. Cancer 109:1870-1876. (Pubitemid 46668553)